Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cyclooxygenase-2
100%
Tumor
70%
Cyclooxygenase-1 (COX-1)
52%
Breast Cancer
50%
Cell Delay
50%
Cancer Onset
50%
Tumor Immune Surveillance
50%
Cell-derived
50%
Mouse Mammary Epithelial Cells
50%
Immune Checkpoint
50%
Mammary Carcinoma Cells
50%
Type 1 Immune Response
50%
CD8+
15%
Mammary Epithelial Cells
13%
Decreased Expression
10%
Orthotopic Tumor
10%
Programmed Cell Death Protein 1 (PD-1)
10%
T Cells
10%
Mammary Tumor
10%
Immune-suppressive
10%
Programmed Death-ligand 1 (PD-L1)
10%
ERBB2
10%
Tumor Cells
10%
Immune Surveillance
10%
CD86
8%
Prostaglandin E2
8%
Ki-67
7%
Cyclooxygenase-2 Inhibitors
7%
Messenger RNA (mRNA)
5%
CD45
5%
Tumor Necrosis Factor-α
5%
Retnla
5%
Robust Growth
5%
SiRNA Delivery
5%
Mouse Mammary Cancers
5%
Th2 Lymphocytes
5%
Control Cell
5%
Transgenic Mice
5%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
5%
Cell Growth
5%
M2 Macrophages
5%
Inflammatory Enzymes
5%
Flow Cytometry
5%
Cytotoxic Immune Cells
5%
Mammary Cancer Cells
5%
Knock
5%
Tumor-infiltrating Leukocytes
5%
Immune Cells
5%
T-bet
5%
Proliferation Marker
5%
Medicine and Dentistry
Breast Cancer
50%
Cyclooxygenase 2
50%
Epithelial Cell
50%
Immune Response
50%
Tumor
50%
Tumor Necrosis Factor
5%
Messenger RNA
5%
Carcinogenesis
5%
Immunology and Microbiology
Immunosurveillance
50%
Carcinoma Cell
50%
Cyclooxygenase
50%
CD8
8%
Immunocompetent Cell
8%
Wild Type
5%
Cancer Cell
5%
Programmed Death-Ligand 1
5%
T Cell
5%
Tumor Cell
5%
